Cargando…
Proteome Multimarker Panel for the Early Detection of Hepatocellular Carcinoma: Multicenter Derivation, Validation, and Comparison
[Image: see text] Conventional methods for the surveillance of hepatocellular carcinoma (HCC) by imaging, with and without serum tumor markers, are suboptimal with regard to accuracy. We aimed to develop and validate a reliable serum biomarker panel for the early detection of HCC using a proteomic t...
Autores principales: | Kim, Ju Yeon, Kim, Jaenyeon, Lim, Young-Suk, Gwak, Geum-Youn, Yeo, Injoon, Kim, Yoseop, Lee, Jihyeon, Shin, Dongyoon, Lee, Jeong-Hoon, Kim, Youngsoo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9434733/ https://www.ncbi.nlm.nih.gov/pubmed/36061641 http://dx.doi.org/10.1021/acsomega.2c02926 |
Ejemplares similares
-
Proteome Multimarker Panel With Multiple Reaction Monitoring–Mass Spectrometry for Early Detection of Hepatocellular Carcinoma
por: Yeo, Injoon, et al.
Publicado: (2020) -
Inclusive Quantification Assay of Serum Des‐γ‐Carboxyprothrombin Proteoforms for Hepatocellular Carcinoma Surveillance by Targeted Mass Spectrometry
por: Lee, Jihyeon, et al.
Publicado: (2021) -
Web portal for analytical validation of MRM-MS assay abided with integrative multinational guidelines
por: Kim, Jaenyeon, et al.
Publicado: (2020) -
Integrating proteomic and clinical data to discriminate major psychiatric disorders: Applications for major depressive disorder, bipolar disorder, and schizophrenia
por: Shin, Dongyoon, et al.
Publicado: (2022) -
Diagnostic performance enhancement of pancreatic cancer using proteomic multimarker panel
por: Park, Jiyoung, et al.
Publicado: (2017)